Abstract
The prevalence of primary liver cancer (PLC) varies throughout the world. It has been attributed to variations in incidence of the predominant histological type, hepatocellular carcinoma (HCC). The incidence of PLC types other than HCC such as cholangiocellular carcinoma (CCC) is far less known, especially in low-incidence areas. The aetiology of HCC and other PLC types is obscure, with the exception of the association between HCC and cirrhosis as well as chronic viral hepatitis. The present retrospective incidence and aetiology study concerns a well-defined population from a period with a high autopsy frequency. Preserved biopsy specimens were re-evaluated histopathologically and patient records were studied. Among 590 histologically verified cases of PLC, HCC constituted 90%, CCC 8% and a mixed form of these types 1%. At the end of the study period the annual age-standardised incidence rate of HCC was 3.6 cases per 100,000 inhabitants. Other PLC types were hepatoblastoma (n = 3), fibrolamellar carcinoma (n = 2), angiosarcoma (n = 1) and infantile haemangioendothelioma (n = 1), each constituting less than 1% of the PLC cases. Comparing HCC with CCC we found that cirrhosis (70%) and alcoholism (21%) was significantly more frequent in HCC, and cholelithiasis was significantly more common (60%) in patients with CCC. In the majority of the PLC cases with liver cirrhosis this disorder was unknown before diagnosis of the tumour.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altaee M. Y., Johnson P. J., Farrant J. M., Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer. 1991 Nov 1;68(9):2051–2055. doi: 10.1002/1097-0142(19911101)68:9<2051::aid-cncr2820680934>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- Bassendine M. F. Aetiological factors in hepatocellular cancer. Baillieres Clin Gastroenterol. 1987 Jan;1(1):1–16. doi: 10.1016/0950-3528(87)90031-5. [DOI] [PubMed] [Google Scholar]
- Bassendine M. F. Alcohol--a major risk factor for hepatocellular carcinoma? J Hepatol. 1986;2(3):513–519. doi: 10.1016/s0168-8278(86)80063-0. [DOI] [PubMed] [Google Scholar]
- Beasley R. P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988 May 15;61(10):1942–1956. doi: 10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Bengmark S., Börjesson B., Hafström L. The natural history of primary carcinoma of the liver. Scand J Gastroenterol. 1971;6(4):351–355. doi: 10.3109/00365527109181132. [DOI] [PubMed] [Google Scholar]
- Bouchier I. A. Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver. Gut. 1969 Sep;10(9):705–710. doi: 10.1136/gut.10.9.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen M. F., Jan Y. Y., Wang C. S., Jeng L. B., Hwang T. L., Chen S. C. Intrahepatic stones associated with cholangiocarcinoma. Am J Gastroenterol. 1989 Apr;84(4):391–395. [PubMed] [Google Scholar]
- Colombo M. Hepatocellular carcinoma. J Hepatol. 1992 May;15(1-2):225–236. doi: 10.1016/0168-8278(92)90041-m. [DOI] [PubMed] [Google Scholar]
- Cook G. C. Hepatocellular carcinoma: one of the world's most common malignancies. Q J Med. 1985 Nov;57(223):705–708. [PubMed] [Google Scholar]
- Dusheiko G. Hepatocellular carcinoma: molecular biology, etiology and animal models. Gastroenterol Clin North Am. 1987 Dec;16(4):575–590. [PubMed] [Google Scholar]
- Ekbom A., Hsieh C. C., Yuen J., Trichopoulos D., McLaughlin J. K., Lan S. J., Adami H. O. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet. 1993 Nov 20;342(8882):1262–1265. doi: 10.1016/0140-6736(93)92359-2. [DOI] [PubMed] [Google Scholar]
- Fukuda A., Sugimachi K., Tokudome S., Ikeda M., Koga S., Hirohata T. Blood transfusion as a risk factor for cirrhosis and liver cancer: a matched case-control study. J Natl Cancer Inst. 1989 Aug 2;81(15):1189–1190. doi: 10.1093/jnci/81.15.1189. [DOI] [PubMed] [Google Scholar]
- Hafström L. Primary liver cancer in Sweden. Ann Chir Gynaecol Suppl. 1986;200:11–12. [PubMed] [Google Scholar]
- Hardell L., Bengtsson N. O., Jonsson U., Eriksson S., Larsson L. G. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer. 1984 Sep;50(3):389–397. doi: 10.1038/bjc.1984.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hey A., Röckelein G. Primäre Leberkarzinome im Sektionsmaterial. Fortschr Med. 1985 Mar 7;103(9):238–242. [PubMed] [Google Scholar]
- Hsing A. W., McLaughlin J. K., Hoover R. N., Co Chien H. T., Blot W. J., Fraumeni J. F., Jr Parity and primary liver cancer among young women. J Natl Cancer Inst. 1992 Jul 15;84(14):1118–1119. doi: 10.1093/jnci/84.14.1118. [DOI] [PubMed] [Google Scholar]
- Johnson P. J. The clinical features and natural history of malignant liver tumours. Baillieres Clin Gastroenterol. 1987 Jan;1(1):17–34. doi: 10.1016/0950-3528(87)90032-7. [DOI] [PubMed] [Google Scholar]
- Kaczynski J., Hansson G., Norkrans G., Wallerstedt S. Lack of correlation between hepatitis B virus infection and the increasing incidence of primary liver cancer in Sweden. Acta Oncol. 1991;30(7):811–813. doi: 10.3109/02841869109091826. [DOI] [PubMed] [Google Scholar]
- Kaczynski J., Wallerstedt S. Registration of liver cancer data--a study on the reliability of the Swedish Cancer Registry. Acta Oncol. 1989;28(5):716–717. doi: 10.3109/02841868909092300. [DOI] [PubMed] [Google Scholar]
- Lambe M., Trichopoulos D., Hsieh C. C., Ekbom A., Pavia M. Parity and hepatocellular carcinoma. A population-based study in Sweden. Int J Cancer. 1993 Nov 11;55(5):745–747. doi: 10.1002/ijc.2910550508. [DOI] [PubMed] [Google Scholar]
- Lander J. J., Stanley R. J., Sumner H. W., Boswell D. C., Aach R. D. Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite). Gastroenterology. 1975 Jun;68(6):1582–1586. [PubMed] [Google Scholar]
- Lawson D. H., Gray J. M., McKillop C., Clarke J., Lee F. D., Patrick R. S. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med. 1986 Oct;61(234):945–955. [PubMed] [Google Scholar]
- Lefkowitch J. H. The epidemiology and morphology of primary malignant liver tumors. Surg Clin North Am. 1981 Feb;61(1):169–180. doi: 10.1016/s0039-6109(16)42341-8. [DOI] [PubMed] [Google Scholar]
- Oka H., Tamori A., Kuroki T., Kobayashi K., Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology. 1994 Jan;19(1):61–66. [PubMed] [Google Scholar]
- Polterauer P., Ulrich W. Das primäre Leberkarzinom. Autoptische Ergebnisse bei 268 Patienten. Onkologie. 1982 Apr;5(2):76–78. doi: 10.1159/000214971. [DOI] [PubMed] [Google Scholar]
- Popper H., Thomas L. B., Telles N. C., Falk H., Selikoff I. J. Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol. 1978 Aug;92(2):349–376. [PMC free article] [PubMed] [Google Scholar]
- Resnick R. H., Koff R. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch Intern Med. 1993 Jul 26;153(14):1672–1677. [PubMed] [Google Scholar]
- Seeff L. B., Beebe G. W., Hoofnagle J. H., Norman J. E., Buskell-Bales Z., Waggoner J. G., Kaplowitz N., Koff R. S., Petrini J. L., Jr, Schiff E. R. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med. 1987 Apr 16;316(16):965–970. doi: 10.1056/NEJM198704163161601. [DOI] [PubMed] [Google Scholar]
- Simonetti R. G., Cammà C., Fiorello F., Politi F., D'Amico G., Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci. 1991 Jul;36(7):962–972. doi: 10.1007/BF01297149. [DOI] [PubMed] [Google Scholar]
- Tamburro C. H., Lee H. M. Primary hepatic cancer in alcoholics. Clin Gastroenterol. 1981 May;10(2):457–477. [PubMed] [Google Scholar]
- Vitale G. C., Heuser L. S., Polk H. C., Jr Malignant tumors of the liver. Surg Clin North Am. 1986 Aug;66(4):723–741. doi: 10.1016/s0039-6109(16)43984-8. [DOI] [PubMed] [Google Scholar]
- Yu M. C., Tong M. J., Govindarajan S., Henderson B. E. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst. 1991 Dec 18;83(24):1820–1826. doi: 10.1093/jnci/83.24.1820. [DOI] [PubMed] [Google Scholar]
- Zaman S. N., Melia W. M., Johnson R. D., Portmann B. C., Johnson P. J., Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet. 1985 Jun 15;1(8442):1357–1360. doi: 10.1016/s0140-6736(85)91785-4. [DOI] [PubMed] [Google Scholar]
